Shenzhen New Industries Biomedical Engineering Co. Ltd Financials

Market Capitalization CN¥43.38 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	23.62
Forward PE	17.66
Price to Sales TTM	CN¥9.36
Price to Book MRQ	CN¥4.82
Enterprise to Revenue	9.07
Enterprise to EBITDA	19.92

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	39.66%
Operating Margin	40.56%
Return on Assets TTM	13.17%
Return on Equity TTM	21.68%

Income Statement

Revenue TTM	CN¥4,638,735,872
Revenue per Share TTM	CN¥5.90
Quarterly Revenue Growth	10.10%
Gross Profit TTM	CN¥3,279,696,896
EBITDA	CN¥2,104,362,457
Net Income to Common TTM	CN¥1,839,747,584
Diluted EPS TTM	CN¥2.34
Quarterly Earnings Growth YoY	2.60%

Balance Sheet

Total Cash MRQ	CN¥2,478,285,824
Total Cash per Share MRQ	CN¥3.15
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.04
Current Ratio MRQ	8.42
Book Value per Share MRQ	CN¥11.46

Cash Flow

Operating Cash Flow TTM	CN¥1,113,241,472
Levered Free Cash Flow TTM	CN¥410,776,544

300832 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	785,718,785
Float Shares	319,551,830
Avg 10 Volume	2,820,674
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.75%
% Held by Institutions	26.11%

Stock Price Summary

Beta	-0.45
Fifty Two Week Low	CN¥49.01
Fifty Two Week High	CN¥97.20
Fifty Two Week Change	-11.98%
Day 50 MA	CN¥56.88
Day 200 MA	CN¥62.53

Dividends and Splits

Forward Annual Dividend Rate	CN¥5.20
Forward Annual Dividend Yield	9.57%
Trailing Annual Dividend Rate	CN¥1.30
Trailing Annual Dividend Yield	2.39%
Payout Ratio	42.71%
Dividend Date
Ex Dividend Date	2025-05-28
Last Split Factor
Last Split Date	2021-05-21